Financial Disclosure
Actualizado
Reviewed
Mayo. 24, 2022
| Panel Member | Role | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Allison Agwu | M | Gilead Sciences, Inc. | Advisory Board, Research Support |
| Merck & Co. | Advisory Board, Research Support, Consultant | ||
| Jason Baker | M | None | N/A |
| Curt Beckwith | M | Gilead Sciences, Inc. | Research Support |
| Roger Bedimo | M | Merck & Co. | Advisory Board, Research Support |
| Gilead Sciences, Inc | Advisory Board | ||
| GSK/ViiV Healthcare | Advisory Board | ||
| Janssen | Advisory Board | ||
| John T. Brooks | M | None | N/A |
| R. Douglas Bruce | M | None | N/A |
| Danielle Campbell | M | Gilead Sciences, Inc. | Advisory Board |
| GSK/ViiV Healthcare | Virtual Community Stakeholder Meeting Attendee | ||
| Geetanjali Chander | M | None | N/A |
| Laura Cheever | M | None | N/A |
| Jennifer Cocohoba | M | Genentech | Research Support |
| Janssen | Research Support | ||
| GSK/ViiV Healthcare | Research Support | ||
| Susan Cu-Uvin | M | None | N/A |
| Eric Daar | M | Gilead Sciences, Inc. | Research Support, Consultant |
| Merck & Co. | Research Support, Consultant | ||
| GSK/ViiV Healthcare | Research Support, Consultant | ||
| Allison Eckard | M | TheraTechnologies | Advisory Board |
| Rajesh Gandhi | M | None | N/A |
| Edward Gardner | M | Cepheid | Research Support |
| Gilead Sciences, Inc. | Research Support | ||
| GSK/ViiV Healthcare | Research Support | ||
| Jomy George | M | None | N/A |
| Thomas Giordano | M | None | N/A |
| David Glidden | M | Gilead Sciences, Inc. | Consultant |
| Merck & Co. | Advisory Board | ||
| Linda Gorgos | M | Gilead Sciences, Inc. | Research Support |
| Pfizer | Research Support | ||
| Merck & Co. | Research Support | ||
| Roche | Research Support | ||
| Birgit Grund | M | None | N/A |
| Vincent Guilamo-Ramos | M | GSK/ViiV Healthcare | Advisory Board, Research Support |
| Roy M. Gulick | C | None | N/A |
| Tim Horn | M | None | N/A |
| Peter Hunt | M | Biotron Limited | Consultant |
| Gilead Sciences, Inc. | Honoraria, Research Support | ||
| GSK/ViiV Healthcare | Honoraria, Consultant | ||
| Merck & Co. | Research Support | ||
| Emily Hyle | M | None | N/A |
| Steven Johnson | M | GSK/ViiV Healthcare | Advisory Board |
| Rami Kantor | M | Gilead Sciences, Inc. | Research Support |
| Andy Kaytes | M | Not Yet Submitted | Not Yet Submitted |
| Marla J. Keller | M | None | N/A |
| Arthur Kim | M | None | N/A |
| Michael Kozal | M | GSK/ViiV Healthcare | Research Support |
| H. Clifford Lane | C | None | N/A |
| Jeffrey Lennox | M | GSK/ViiV Healthcare | Research Support |
| Susan Little | M | Gilead Sciences, Inc. | Research Support, Other: Donation of Medications |
| Henry Masur | M | None | N/A |
| Susanna Naggie | M | AbbVie Pharma | Research Support |
| Bristol Myers Squibb/ PRA Health Sciences, Inc. | Event Adjudication Committee | ||
| Gilead Sciences, Inc. | Research Support | ||
| Silverback Therapeutics | Consultant | ||
| David Palm | M | None | N/A |
| Alice K. Pau | ES | None | N/A |
| Tonia Poteat | M | GSK/ViiV Healthcare | Consultant |
| Merck & Co. | Consultant | ||
| Asa Radix | M | None | N/A |
| Daniel Reirden | M | Gilead Sciences, Inc. | Research Support |
| Virginia Sheikh | M | None | N/A |
| Serena Spudich | M | GSK/ViiV Healthcare | Research Support, Other: Donation of Medications |
| Kimberly Struble | M | None | N/A |
| Susan Swindells | M | GSK/ViiV Healthcare | Research Support |
| Babafemi Taiwo | M | Gilead Sciences, Inc. | Advisory Board |
| GSK/ViiV Healthcare | Advisory Board | ||
| Johnson & Johnson | Advisory Board | ||
| Merck & Co. | Advisory Board | ||
| Pablo Tebas | M | Gilead Sciences, Inc. | Advisory Board |
| GSK/ViiV Healthcare | Advisory Board | ||
| Merck & Co. | Advisory Board | ||
| Melanie Thompson | M | GSK/ViiV Healthcare | Advisory Board |
| CytoDyn | Research Support | ||
| Gilead Sciences, Inc. | Research Support | ||
| Merck & Co. | Advisory Board | ||
| Steven Vargas | M | None | N/A |
| Key: C = Co-Chair; ES = Executive Secretary; M = Member; N/A = not applicable | |||
Download Guidelines
- Section OnlyPDF (78.52 KB)
- Full GuidelinePDF (4.63 MB)
- Recommendations OnlyPDF (675.94 KB)
- Tables OnlyPDF (2.24 MB)